Welcome to our dedicated page for AMKOR TECHNOLOGY SEC filings (Ticker: AMKR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amkor Technology Inc. filings document the regulatory record for a Nasdaq-listed outsourced semiconductor packaging and test company. The company’s 8-K reports furnish results of operations and financial condition, disclose material agreements and other events, and describe capital-structure matters involving common stock, senior notes and convertible senior notes.
AMKR filings also cover governance and ownership subjects through definitive proxy materials, officer appointments and underwriting agreements related to registered secondary offerings. Recent debt disclosures describe 0.00% convertible senior notes due 2031, subsidiary guarantees and their relationship to other senior unsecured indebtedness, while earnings-related filings include non-GAAP measures such as EBITDA alongside GAAP results.
AMKOR TECHNOLOGY, INC. (AMKR) reported that its Chief Financial Officer, Megan Faust, sold 1,000 shares of common stock on September 8, 2026 in an open-market or private transaction at $49.05 per share. Following this sale, she held 134,105 shares directly. The sale was effected under a Rule 10b5-1 trading plan adopted by the reporting person.
Amkor Technology, Inc. (AMKR) has an officer, Megan Faust, filing a notice under Rule 144 to sell 1,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an indicated value of $49,050. The 1,000 shares relate to performance shares from December 31, 2022, and follow three prior sales of 1,000 shares each over the past three months.
AMKOR TECHNOLOGY, INC. (AMKR) insider Mark N. Rogers, EVP & General Counsel, reported an option exercise and related sale. On August 17, 2026, he exercised 5,000 stock options at $7.40 per share into 5,000 shares of common stock, then sold 5,000 shares at $59.78 per share under a Rule 10b5-1 trading plan adopted on August 1, 2025. Following the option transaction, he held 70,000 stock options from this grant, which originally covered 200,000 shares and vested over four years.
AMKR insider Mark N. Rogers filed a notice to sell 5,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $298,900.00, in a transaction related to a stock option exercise dated August 17, 2026.
Rogers also reports prior sales of 5,000 shares of common stock on each of May 18, 2026 ($358,150.00), June 16, 2026 ($431,050.00), and July 16, 2026 ($325,600.00).
Amkor Technology, Inc. CFO Megan Faust reported the sale of 1,000 shares of common stock on August 11, 2026 at $54.45 per share. Following this transaction, she directly holds 135,105 shares. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 17, 2026.
Amkor Technology, Inc. director Douglas A. Alexander exercised stock options and sold shares on August 7, 2026. He exercised a Director Stock Option to acquire 5,000 shares of common stock at an exercise price of $8.51 per share, then sold 5,000 shares of common stock at $55.81 per share in a sale described as an open market or private transaction. The option exercised was part of a grant covering 20,000 shares that vested in full on May 1, 2019. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 8, 2026.
Shareholder Megan Faust filed to sell 1,000 shares of Amkor Technology common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an indicated market value of $54,450.00 and an intended sale date of August 11, 2026 on the NASDAQ. The filing also lists three prior sales of 1,000 shares each over the preceding three months.
Amkor Technology, Inc. director Guillaume Marie Jean Rutten reported selling a total of 50,000 shares of Common Stock in two open market or private transactions on August 5 and 6, 2026. The weighted average prices were $55.35 and $54.50 per share, with individual trades executed within disclosed price ranges. The sales were reported as direct ownership transactions and were not indicated as made under a Rule 10b5-1 trading plan.
Guillaume Rutten filed a notice to sell restricted shares of AMKR common stock. The filing lists 25,000 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $1,362,607.50 and 248,452,472 common shares outstanding, as of a proposed sale date of 08/06/2026 on NASDAQ. It also notes that the securities derive from performance shares dated 08/13/2024.
Over the past three months, the filing reports prior sales of AMKR common stock by Guillaume Rutten: 25,000 shares on 08/05/2026 for $1,383,765.00 and 50,000 shares on 05/08/2026 for $3,713,965.00.